EUVIMEDEUVIMED entdecken
Multizentrische Studie

Clinical Manifestations and Prognosis of Patients With Mucormycosis in Intensive Care Units in Western China: A Multi‐Center Retrospective Study

Fuxun Yang, Yi Zhang, Bo Qi, Li Chen, Fang Lin, Jiani Wu, Sihan Gong, Lianghai Cao, Mingquan Zeng, Qiong Cheng, Dexiong Jiang, Shiyuan Tang und 9 weitere

Mycoses · 2025

DOI: 10.1111/myc.70042 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Mycoses, 2025. Verfasst von Fuxun Yang und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of ICU, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China. Hauptthemen laut MEDLINE: Mucormycosis, Intensive Care Units. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Research Fund of Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital, Sichuan Science and Technology Program, Sichuan Provincial Science and Technology Support Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mucormycosis is a life‐threatening fungal infection with high mortality in critically ill patients. Clinical manifestations and outcomes of mucormycosis in intensive care units (ICUs) remain poorly investigated.

Methods

We conducted a multicenter retrospective study including 43 adult patients with confirmed mucormycosis admitted to 14 tertiary ICUs between January 2014 and May 2022. Clinical characteristics, diagnostic approaches, treatment strategies, and outcomes were analysed.

Results

The mean age was 56.8 ± 16.2 years, with 16/43 (37.2%) female patients. The 28‐day survival rate was 46.5% (20/43). Lung involvement was predominant (29/43, 67.4%), and 29/43 (67.4%) patients received amphotericin B therapy. Survivors showed significantly better treatment response compared to non‐survivors (16/20, 80% vs. 4/23, 17.4%, p < 0.001). Non‐survivors demonstrated significantly higher levels of aspartate aminotransferase, C‐reactive protein, and white blood cells, along with lower albumin levels. Metagenomic next‐generation sequencing (mNGS) was associated with a shorter time to diagnosis. Multivariate analysis identified age, respiratory failure, time from symptom onset to diagnosis, and antifungal treatment response as independent predictors of 28‐day mortality (AUC = 0.852).

Conclusion

In critically ill patients with mucormycosis, early diagnosis and prompt targeted therapy are crucial determinants of survival, with our newly developed prediction model providing a practical tool for risk stratification, while mNGS shows promise in expediting diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MucormycosisIntensive Care UnitsHumansRetrospective StudiesFemaleMiddle AgedMaleChinaAntifungal AgentsAgedPrognosisAdultTreatment OutcomeCritical IllnessAmphotericin B

Stichwörter der Autor:innen

critical careearly diagnosismetagenomic next‐generation sequencingmucormycosisprognosis

Substanzen

Antifungal AgentsAmphotericin B

Autor:innen und Institutionen

  • Department of ICU, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
  • Department of Intensive Care Unit, 903 Hospital, Mianyang, China.
  • Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China.
  • Department of Respiratory and Critical Care Medicin, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
  • Department of Critical Care Medicine, Chengdu Sixth People's Hospital, Chengdu, China.
  • Department of Respiratory and Critical Care Medicine, People's Hospital of Tong Jiang Sichuan, Bazhong, China.

ORCID-Profile: Yunping Lan

Förderung

  • Research Fund of Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital
  • Sichuan Science and Technology Program
  • Sichuan Provincial Science and Technology Support Program

Zitieren

APA

Yang, F., Zhang, Y., Qi, B., Chen, L., Lin, F., Wu, J., Gong, S., Cao, L., Zeng, M., Cheng, Q., Jiang, D., Tang, S., He, J., Xu, Z., Li, T., Ni, Z., Li, Y., Huang, X., Pan, C., …, & Lan, Y. (2025). Clinical Manifestations and Prognosis of Patients With Mucormycosis in Intensive Care Units in Western China: A Multi‐Center Retrospective Study. Mycoses. https://doi.org/10.1111/myc.70042

Vancouver

Yang F, Zhang Y, Qi B, Chen L, Lin F, Wu J, et al. Clinical Manifestations and Prognosis of Patients With Mucormycosis in Intensive Care Units in Western China: A Multi‐Center Retrospective Study. Mycoses. 2025. doi:10.1111/myc.70042

BibTeX
@article{Yang2025,
  author = {Yang, Fuxun and Zhang, Yi and Qi, Bo and Chen, Li and Lin, Fang and Wu, Jiani and Gong, Sihan and Cao, Lianghai and Zeng, Mingquan and Cheng, Qiong and Jiang, Dexiong and Tang, Shiyuan and He, Jieming and Xu, Zhihua and Li, Tun and Ni, Zhen and Li, Yachao and Huang, Xiaobo and Pan, Chun and Liu, Rongan and Lan, Yunping},
  title = {Clinical Manifestations and Prognosis of Patients With Mucormycosis in Intensive Care Units in Western China: A Multi‐Center Retrospective Study},
  journal = {Mycoses},
  year = {2025},
  doi = {10.1111/myc.70042}
}
Kostenlos starten →